6:14 PM
 | 
Dec 05, 2012
 |  BC Extra  |  Company News

AZ planning job cuts in Germany

AstraZeneca plc (LSE:AZN; NYSE:AZN) said it plans to reduce headcount by about 400 (39%) to about 625 in Germany, citing the country's mandatory 16% drug rebates and pricing freeze, changes in the pharma's product portfolio and delays in R&D. The planned cuts would come primarily from the pharma's sales force and internal support staff. An AstraZeneca spokesperson said the cuts...

Read the full 284 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >